Prudential Financial
TXG icon

Prudential Financial’s 10x Genomics TXG Stock Holding History

Prudential Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
27,450
-35,720
-57% -$936K ﹤0.01% 1643
2026
Q1 		$1.34M Buy
+63,170
New +$1.26M ﹤0.01% 1487
2025
Q4 		– Sell
-35,700
Closed -$417K – 2444
2025
Q3 		$417K Buy
35,700
+21,775
+156% +$284K ﹤0.01% 2008
2025
Q2 		$161K Buy
+13,925
New +$127K ﹤0.01% 2242
2022
Q1 		– Sell
-12,850
Closed -$1.95M – 2697
2021
Q4 		$1.95M Sell
12,850
-24
-0.2% -$3.68K ﹤0.01% 1555
2021
Q3 		$1.91M Sell
12,874
-6,304
-33% -$1.08M ﹤0.01% 1487
2021
Q2 		$3.76M Buy
19,178
+550
+3% +$99.5K 0.01% 1156
2021
Q1 		$3.37M Sell
18,628
-27
-0.1% -$4.66K 0.01% 1203
2020
Q4 		$2.64M Buy
18,655
+4,311
+30% +$626K ﹤0.01% 1296
2020
Q3 		$1.79M Sell
14,344
-6,586
-31% -$691K ﹤0.01% 1369
2020
Q2 		$1.87M Buy
+20,930
New +$1.63M ﹤0.01% 1368

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prudential Financial's TXG Position: Q2 2026 in Review

Prudential Financial reduced its 10x Genomics (TXG) stake by 57% in Q2 2026, selling an estimated $936K and leaving 27,450 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Prudential Financial first reported a position in TXG in Q2 2020 and has held it in 11 quarters since. The position peaked at $3.76M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Prudential Financial held 27,450 shares of 10x Genomics worth $1.05M as of Q2 2026.
  • Prudential Financial sold 35,720 10x Genomics shares in Q2 2026, an estimated $936K.
  • 10x Genomics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1643 holding.
  • Prudential Financial first reported a position in 10x Genomics in Q2 2020 and has held it in 11 quarters since.
  • Prudential Financial's 10x Genomics position peaked at $3.76M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.